Table 2

Supplementation impact on malaria and general morbidity

Placebo

Supplemented

RR (95% CI)

p-value


Number of fever episodes (mean ± SD)

2.04 ± 1.2

1.63 ± 1.2

-

0.038

Number of malaria episodes (mean ± SD)

1.5 ± 1.005

1 ± 0.93

-

0.029

P*PFever episodes

153

119

1.28 (1.09–2.94)

0.030

P*PMalaria episodes

106

74

1.43 (1.10–2.40)

0.025

Free of pathologies

17% (9–25)

31% (16–46)

-

0.05

Cough episodes

51,3 (40–62.6)

45,9% (34.6–57.2)

-

0.510

Diarrhea episodes

52,7% (41.4–64)

28,3% (18.1–38.5)

-

0.002

Geometric mean density P falciparum (asexual forms/μl)

10672 (7589–15007)

7704 (5409–10971)

-

0.049


P*PNumber of episodes

Mean ± SD or % (CI 95%)

Child-years was 37 in each group

Zeba et al. Nutrition Journal 2008 7:7   doi:10.1186/1475-2891-7-7

Open Data